Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01901367 · ClinicalTrials.gov registry record · NA

ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients

A NA study of Childhood Acute Lymphoblastic Leukemia in Remission, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01901367 is a NA study of Childhood Acute Lymphoblastic Leukemia in Remission that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 33 participants, below the 212-participant average among 9 other Childhood Acute Lymphoblastic Leukemia in Remission trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01901367, a NA study of Childhood Acute Lymphoblastic Leukemia in Remission, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This randomized pilot phase II trial studies how well nutritional intervention and exercise intervention works in preventing metabolic syndrome in younger patients with acute lymphoblastic leukemia. Nutritional intervention may help weight loss and improve quality of life in patients with acute lymphoblastic leukemia. Exercise may help decrease feelings of being tired caused by cancer, may help improve strength, and may help build up lost muscle tissue. Nutritional intervention plus exercise intervention may be effective at preventing metabolic syndrome.

Conditions Studied

Childhood Acute Lymphoblastic Leukemia in Remission

Interventions

  • OTHER quality-of-life assessment
  • BEHAVIORAL exercise intervention
  • DIETARY_SUPPLEMENT nutritional intervention
  • OTHER follow-up care
  • BEHAVIORAL counseling intervention

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2013-05
Est. Completion 2015-09
Phase NA

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01901367

The ClinicalTrials.gov registry entry for NCT01901367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 212-participant average among 9 other Childhood Acute Lymphoblastic Leukemia in Remission trials with a reported enrollment target (84% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Childhood Acute Lymphoblastic Leukemia in Remission appearing as the primary indexed condition, and to 5 interventions - of which quality-of-life assessment is the first listed.

NCT01901367 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT01901367 about?

NCT01901367 is a clinical study titled "ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients". This randomized pilot phase II trial studies how well nutritional intervention and exercise intervention works in preventing metabolic syndrome in younger patients with acute lymphoblastic leukemia. Nutritional intervention may help weight loss and improve quality of life in patients with acute lymp...

What is the current status of trial NCT01901367?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2013-05. Estimated completion is 2015-09.

What conditions does trial NCT01901367 study?

This clinical trial studies the following conditions: Childhood Acute Lymphoblastic Leukemia in Remission.

What interventions are being tested in trial NCT01901367?

The interventions under investigation include: quality-of-life assessment (OTHER), exercise intervention (BEHAVIORAL), nutritional intervention (DIETARY_SUPPLEMENT), follow-up care (OTHER), counseling intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01901367?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01901367 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Childhood Acute Lymphoblastic Leukemia in Remission

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Childhood Acute Lymphoblastic Leukemia in Remission

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.